Similar Papers

Paper Title
Journal
Date
Author
Abstract 1686: TSC2 enhances antitumor immunity and potentiates PD-1 and CTLA-4 blockade
Heng-Jia Liu ... Patrick Lizotte
Cancer Research | VOL. 78
Heng-Jia Liu, et. al.Heng-Jia Liu ... Patrick Lizotte
01 Jul 2018
Immunotherapy-based therapy versus chemotherapy for the neoadjuvant treatment of locally advanced dMMR/MSI-H gastric cancer.
Pengfei Zhang ... Hongfeng Gou
Journal of Clinical Oncology | VOL. 42
Pengfei Zhang, et. al.Pengfei Zhang ... Hongfeng Gou
01 Jun 2024
Abstract PR05: Combination therapy with anti-CTLA4 and anti-PD1 leads to distinct immunologic changes in-vivo
Rituparna Das ... Kavita Dhodapkar
Cancer Research | VOL. 75
Rituparna Das, et. al.Rituparna Das ... Kavita Dhodapkar
15 Jul 2015
830 Targeting B cell suppression to improve the efficacy of immunotherapies in brain cancer
David Hou ... Benjamin Izar
Journal for ImmunoTherapy of Cancer | VOL. 10
David Hou, et. al.David Hou ... Benjamin Izar
01 Nov 2022
View more papers

More From: Cancer biology & medicine

Paper Title
Journal
Date
Author
Local consolidative therapy in oligometastatic non-small-cell lung cancer after effective systemic treatment: who will benefit?
Jiayi Deng ... Qing Zhou
Cancer biology & medicine | VOL. -
Jiayi Deng, et. al.Jiayi Deng ... Qing Zhou
07 Jan 2025
Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents.
Jinge Zhao ... Hao Zeng
Cancer biology & medicine | VOL. 21
Jinge Zhao, et. al.Jinge Zhao ... Hao Zeng
24 Dec 2024
Deciphering the cell surface glyco-code: a promising perspective on unveiling the vulnerability of cancer stem cells.
Yuanyan Wei ... Jianhai Jiang
Cancer biology & medicine | VOL. -
Yuanyan Wei, et. al.Yuanyan Wei ... Jianhai Jiang
11 Dec 2024
Elucidating the synergistic roles of CD4+ T and dendritic cells in antitumor immunity.
Xiubao Ren
Cancer biology & medicine | VOL. -
Xiubao RenXiubao Ren
11 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.